Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown

Open Access

Peer-reviewed

Research Article

Nannan Zhou,

Affiliation Department of Virology, R&D of Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America
⨯
Bo Ding,

Affiliation Department of Virology, R&D of Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America
⨯
Michele Agler,

Current address: High Throughput Biology, Boehringer Ingelheim, Ridgefield, Connecticut, United States of America

Affiliation Department of Leads Discovery, R&D of Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America
⨯
Mark Cockett,

Affiliation Department of Virology, R&D of Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America
⨯
Fiona McPhee

* E-mail: Fiona.McPhee@bms.com

Affiliation Department of Virology, R&D of Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America
⨯

Reader Comments (0)

HeLa cells
Is the Subject Area "HeLa cells" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cervical cancer
Is the Subject Area "Cervical cancer" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Lentivirus
Is the Subject Area "Lentivirus" applicable to this article?

Thanks for your feedback.
Autophagic cell death
Is the Subject Area "Autophagic cell death" applicable to this article?

Thanks for your feedback.
RNA interference
Is the Subject Area "RNA interference" applicable to this article?

Thanks for your feedback.
Protein expression
Is the Subject Area "Protein expression" applicable to this article?

Thanks for your feedback.